+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Stomach Cancer Drug"

From
From
From
From
Gastric Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Gastric Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HER+ Gastric Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

HER+ Gastric Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HER2+ Gastric Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

HER2+ Gastric Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
US Stomach Cancer Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Stomach Cancer Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
From
Gastric Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Gastric Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 2657 Pages
  • Global
From
Loading Indicator

Stomach cancer, also known as gastric cancer, is a type of cancer that affects the lining of the stomach. Oncology drugs are used to treat this type of cancer, and the stomach cancer drug market is a subset of the larger oncology drug market. These drugs are used to treat both early and advanced stages of stomach cancer, and can be administered orally, intravenously, or through injections. They can also be used in combination with other treatments such as chemotherapy and radiation therapy. The stomach cancer drug market is highly competitive, with many companies developing and marketing drugs for the treatment of this type of cancer. Some of the major players in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to improve the treatment of stomach cancer. Show Less Read more